These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3018762)
1. Corticotropin-releasing activity in the rat gastric antrum. Uehara A; Minamino N; Townsend MH; Arimura A Proc Soc Exp Biol Med; 1986 Oct; 183(1):106-13. PubMed ID: 3018762 [TBL] [Abstract][Full Text] [Related]
2. Biological and immunological characterization of corticotropin-releasing activity in the bovine adrenal medulla. Minamino N; Uehara A; Arimura A Peptides; 1988; 9(1):37-45. PubMed ID: 2834703 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of dithiothreitol and iodoacetamide on corticotropin-releasing factor (CRF) activity of bovine hypothalamic CRFs and vasopressin. Yasuda N; Aizawa T; Greer MA Endocrinology; 1982 Jun; 110(6):2074-80. PubMed ID: 6280987 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro release of ACTH by synthetic CRF. Turkelson CM; Arimura A; Culler MD; Fishback JB; Groot K; Kanda M; Luciano M; Thomas CR; Chang D; Chang JK; Shimizu M Peptides; 1981; 2(4):425-9. PubMed ID: 6276870 [TBL] [Abstract][Full Text] [Related]
5. Thymosin fraction 5 (TF5) stimulates secretion of adrenocorticotropic hormone (ACTH) from cultured rat pituitaries. McGillis JP; Hall NR; Goldstein AL Life Sci; 1988; 42(22):2259-68. PubMed ID: 2453772 [TBL] [Abstract][Full Text] [Related]
6. High molecular weight peptide with corticotropin-releasing factor activity from porcine hypothalami. Schally AV; Chang RC; Arimura A; Redding TW; Fishback JB; Vigh S Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5197-201. PubMed ID: 6975479 [TBL] [Abstract][Full Text] [Related]
7. ACTH release in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF). Hashimoto K; Yunoki S; Takahara J; Ofuji T Endocrinol Jpn; 1979 Feb; 26(1):103-9. PubMed ID: 35343 [TBL] [Abstract][Full Text] [Related]
8. Characterization of corticotropin releasing factor (CRF) and arginine vasopressin in median eminence extracts on sephadex gel-filtration. Hashimoto K; Ohno N; Yunoki S; Kageyama J; Aoki Y; Takahara J; Ofuji T Endocrinol Jpn; 1981 Feb; 28(1):1-7. PubMed ID: 6972867 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological properties of ovine corticotropin-releasing factor (CRF). Sueiras-Diaz J; Coy DH; Vigh S; Redding TW; Huang WY; Torres-Aleman I; Schally AV Life Sci; 1982 Aug; 31(5):429-35. PubMed ID: 6290814 [TBL] [Abstract][Full Text] [Related]
10. Corticotrope response to removal of releasing factors and corticosteroids in vivo. Dallman MF; Makara GB; Roberts JL; Levin N; Blum M Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro comparisons of biological activities of bovine, ovine and rat CRF (corticotrophin-releasing factor). Yasuda N; Yasuda Y; Aizawa T; Maruta S; Greer MA Acta Endocrinol (Copenh); 1984 Jun; 106(2):158-67. PubMed ID: 6328821 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of dynamics of corticotropin-releasing factor (CRF) activity in the rat hypothalamus under stress]. Fujieda K Hokkaido Igaku Zasshi; 1976 May; 51(3):199-216. PubMed ID: 184025 [TBL] [Abstract][Full Text] [Related]
13. Corticotropin releasing factor (CRF)-like immunoreactivity in the hypothalamus and posterior pituitary of the goat, bovine, rat, monkey and human. Hashimoto K; Murakami K; Hattori T; Niimi M; Fujino K; Ota Z Endocrinol Jpn; 1984 Feb; 31(1):7-13. PubMed ID: 6428866 [TBL] [Abstract][Full Text] [Related]
14. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883 [TBL] [Abstract][Full Text] [Related]
15. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami. Ackland JF; Ratter SJ; Bourne GL; Rees LH J Endocrinol; 1986 Feb; 108(2):171-80. PubMed ID: 3485168 [TBL] [Abstract][Full Text] [Related]
16. [The development of immunoreactive corticotropin-releasing factor (IR-CRF) in the hypothalamus, pancreas and gastrointestinal tract of immature rats]. Ohtsuka K; Koshimizu T; Ohyama Y; Yokota Y Nihon Naibunpi Gakkai Zasshi; 1986 Jan; 62(1):34-44. PubMed ID: 3486137 [TBL] [Abstract][Full Text] [Related]
17. Interaction between hypothalamic peptides in a superfused pituitary cell system. Vigh S; Schally AV Peptides; 1984; 5 Suppl 1():241-7. PubMed ID: 6207510 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline. Hadley AJ; Kumari M; Cover PO; Osborne J; Poyser R; Flack JD; Buckingham JC Br J Pharmacol; 1996 Oct; 119(3):463-70. PubMed ID: 8894165 [TBL] [Abstract][Full Text] [Related]
19. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary. Aubry JM; Turnbull AV; Pozzoli G; Rivier C; Vale W Endocrinology; 1997 Apr; 138(4):1621-6. PubMed ID: 9075723 [TBL] [Abstract][Full Text] [Related]
20. [Effects of synthetic ovine corticotropin-releasing factor (CRF) on ACTH release in vitro]. Murakami K; Hashimoto K; Kageyama Z; Takahara J; Ota Z Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):983-92. PubMed ID: 6313440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]